KLK3 and benign prostatic hyperplasia: This confirmed the impossibility of serum PSA to discriminate Pca from BPH patients, while the plasmatic levels of exosomes expressing PSA clearly distinguished not only cancer patients from healthy individuals but cancer patients from patients with a non-tumor condition, such as BPH [36].